Drug Therapy, CombinationTreatment OutcomeDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsAntitubercular AgentsCyclophosphamideAnti-Bacterial AgentsCombined Modality TherapyTime FactorsPatient ComplianceDose-Response Relationship, DrugDrug CombinationsAnti-HIV AgentsAdministration, OralAntineoplastic AgentsPyrazinamideTreatment FailureVincristineHIV InfectionsRetrospective StudiesRifampinIsoniazidDoxorubicinProspective StudiesFluorouracilCisplatinMethotrexateSurvival AnalysisRecurrencePrednisoneTuberculosis, Multidrug-ResistantClinical Trials as TopicMetronidazoleFollow-Up StudiesDouble-Blind MethodDisease-Free SurvivalAmoxicillinEthambutolEtoposideSurvival RateInfusions, IntravenousBismuthImmunosuppressive AgentsPrognosisClarithromycinRemission InductionDrug SubstitutionAntiretroviral Therapy, Highly ActiveDoxycyclineAntibiotics, AntitubercularAntimalarialsDiarylquinolinesMedication AdherenceDeoxycytidineCytarabineTuberculosisPaclitaxelAnti-Infective AgentsRandomized Controlled Trials as TopicBenzoxazinesArtemisininsSalvage TherapyRitonavirViral LoadAntiviral AgentsAntibodies, MonoclonalAnti-Ulcer AgentsDrug Resistance, ViralNeoplasm StagingReverse Transcriptase InhibitorsHIV Protease InhibitorsDirectly Observed TherapyHelicobacter pyloriArea Under CurveAntineoplastic Agents, AlkylatingOfloxacinPenicillin G BenzathineHelicobacter InfectionsVinblastineMicrobial Sensitivity TestsChemotherapy, AdjuvantHIV-1LeucovorinNeoplasmsPenicillinsTuberculosis, PulmonaryOmeprazoleTinidazoleLeprostatic AgentsRandom AllocationLung NeoplasmsLymphoma, Non-HodgkinAzithromycinPilot ProjectsCarboplatinDrug CostsIfosfamideTaxoidsCD4 Lymphocyte CountNeutropenia